Antiepileptic drugs in children in developing countries: research and treatment guideline needs

Area of Science:

• Neurology
• Pediatrics
• Global Health

Background:

• Epilepsy is the most frequent neurologic disorder among children globally.
• Despite available effective treatments, a significant treatment gap exists, exceeding 80% in many developing countries.
• Limited access to essential antiepileptic drugs (AEDs) is a primary driver of this treatment disparity.

Purpose of the Study:

• To analyze the underlying reasons for the substantial treatment gap in pediatric epilepsy care.
• To identify and discuss potential strategies for improving access to epilepsy treatment for children worldwide.
• To highlight the global health implications of untreated or undertreated childhood epilepsy.

Main Methods:

• This article presents a review and discussion of existing literature and data.
• It synthesizes information on the epidemiology of childhood epilepsy.
• It examines barriers to accessing antiepileptic drugs (AEDs) in resource-limited settings.

Main Results:

• The primary barrier identified is the restricted availability and accessibility of antiepileptic drugs (AEDs).
• Socioeconomic factors, healthcare infrastructure limitations, and drug supply chain issues contribute significantly to the treatment gap.
• Lack of awareness and diagnostic challenges further exacerbate the problem.

Conclusions:

• Addressing the childhood epilepsy treatment gap requires multifaceted interventions focused on improving AED access.
• Strengthening healthcare systems and implementing targeted drug subsidy programs are crucial.
• Global collaboration and policy changes are essential to ensure equitable epilepsy care for all children.